Hematological Malignancies

Treatment of cancers of the blood and lymphatic systems, including acute and chronic leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma and plasmacytoma.

Advances in Treatment

Dramatic advances have been made in recent years for most hematological cancers because of research. Novel targeted therapies, which complement or replace traditional chemotherapy and radiation treatments, are now routine for many hematological malignancies.

We offer clinical trials for these disorders, with a focus on immunotherapy, targeted agents and new chemotherapy treatments.